fax: 314-289-7035
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors†
Article first published online: 28 NOV 2007
DOI: 10.1002/hep.21927
Copyright © 2007 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Kanwal, F., Hoang, T., Spiegel, B. M.R., Eisen, S., Dominitz, J. A., Gifford, A., Goetz, M. and Asch, S. M. (2007), Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors. Hepatology, 46: 1741–1749. doi: 10.1002/hep.21927
- †
Potential conflict of interest: Dr. Spiegel is a consultant for and received grants from Tap Pharmaceutical, AstraZeneca, and Novartis. He received grants from Amgen, Johnson & Johnson, Ethicon, and Procter & Gamble.
- ‡
fax: 314-289-7035
Publication History
- Issue published online: 28 NOV 2007
- Article first published online: 28 NOV 2007
- Manuscript Accepted: 16 JUL 2007
- Manuscript Received: 14 APR 2007
Funded by
- VA HIV-Hepatitis Quality Enhancement Research Initiatives (QUERI) core research funds
References
- 1, , , , , , et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–562.
- 2, , , , , . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705–714.
- 3, , , . Burden of liver disease in the United States: summary of a workshop. HEPATOLOGY 2002; 36: 227–242.
- 4, , , , . Trends in health care resource use for hepatitis C virus infection in the United States. HEPATOLOGY 2005; 42: 1406–1413.
- 5, , , , , . Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. HEPATOLOGY 2005; 41: 790–800.
- 6, . Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels. Aliment Pharmacol Ther 2006; 23: 777–785.
- 7, , , , , , et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 1303–1313.
- 8, , , , , , et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 142: 105–114.
- 9, , , , , . Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. HEPATOLOGY 2005; 41: 790–800.
- 10VA Diagnosis and Treatment Recommendations for patients with HCV. Available at http://www.hepatitis.va.gov/vahep?page=tp03–00-00. Accessed June 2007.
- 11, . American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231–264.
- 12, . National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. HEPATOLOGY 2002; 36( Suppl): S1–S2.
- 13, , , . Diagnosis, management, and treatment of hepatitis C. HEPATOLOGY 2004; 39: 1147–1171.
- 14, , , , , , et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100: 1772–1779.Direct Link:
- 15, , , , , , et al. Limited success of HCV antiviral therapy in United States veterans. Am J Gastroenterol 2002; 97: 149–155.Direct Link:
- 16, , , , , . Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288–292.
- 17, . A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol. 2002; 34: 268–271.
- 18, , , . Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42: 411–415.
- 19, , . Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women: a conceptual model. J Gen Intern Med 2003; 18: 854–863.
- 20. Variation in the delivery of health care: the stakes are high. Ann Intern Med 1998; 128: 866–868.
- 21. Practice variation: implications for our health care system. Manag Care 2004; 13(9 Suppl ): 3–7.
- 22, , , , , , et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med 1999; 340: 32–39.
- 23, . Geographic variation, physician characteristics, and diabetes care disparities in a metropolitan area, 2003-2004. Diabetes Res Clin Pract 2006; 72: 162–169.
- 24, , , . Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med 1982; 307: 1310–1314.
- 25, , , , , , et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 1999; 281: 627–633.
- 26, , , , . Geographic variation in expenditures for physicians' services in the United States. N Engl J Med 1993; 328: 621–627.
- 27, , , , . Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998; 279: 1278–1281.
- 28Clinical Classifications Software (CCS) for ICD-9-CM. Available at http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed June 2007.
- 29, , , , , , et al. Black patients with chronic hepatitis C have a lower sustained response rate then non-black with genotype1, but the same with genoype 2/3. J Viral Hepatol 2006; 13: 242–249.
- 30, , , , , . Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol 2006; 59: 18–25.
- 31. Multilevel Analysis. Thousand Oaks, CA: Sage Publications; 2002.
- 32, , , , . Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction: an analysis using hierarchical logistic regression. Med Care 1995; 33: 625–642.
- 33. Predictive accuracy and explained variation. Stat Med 2003; 22: 2299–2308.
- 34SAS statistical program, version 8.1 ( SAS Inc., Cary, NC), 2006.
- 35, , , , , . Rate and predictors of treatment prescription for hepatitis C. Gut 2006; 56: 385–389.
- 36, , , . Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus. J Viral Hepatol 2006; 13: 799–810.
- 37Institute of Medicine. Crossing the Quality Chasm. Washington, DC: National Academy Press; 2001.